HQL
Tekla Life Sciences Investors
NYSE · Financial Services · Asset Management · US
$20.64
−0.34%Latest reported
- Last report date
- Jun 24, 2025
- EPS actual
- -$1.64
- EPS estimate
- —
- Revenue actual
- $18.2M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jun 24, 2025